| Financial Year |
March 31 2023 |
| Monetary Funds |
155,208,061.35 |
| Held-for-trading Financial Assets |
71,584,707.20 |
| Notes Receivable |
23,316,487.70 |
| Accounts Receivable |
203,043,968.29 |
| Advances to Suppliers |
25,139,524.22 |
| Other Receivables |
15,210,988.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
276,843,948.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,189,403.66 |
| Total Current Assets |
822,095,083.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
865,000.00 |
| Long-term Equity Investment |
293,837.77 |
| Investment Properties |
3,008,396.75 |
| Fixed Assetes |
646,504,217.37 |
| Under-construction Projects |
38,521,021.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,769,673.65 |
| R&D expenses |
-- |
| Goodwill |
19,720,669.32 |
| Long-Term Deferred and Prepaid Expenses |
44,139,996.10 |
| Deferred Income Tax Assets |
66,899,083.36 |
| Other Non-Current Assets |
13,019,235.70 |
| Sub-Total of Non-Current Assets |
977,367,001.38 |
| Total Assets |
1,799,462,084.64 |
| Short-Term Loans |
343,814,583.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
59,112,065.57 |
| Accounts Payable |
132,112,015.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,474,129.04 |
| Taxes Payable |
12,708,056.46 |
| Interest Payable |
-- |
| Dividend Payable |
56,325.00 |
| Other payables |
13,085,593.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,160,454.12 |
| Other Current Liabilities |
1,482,265.78 |
| Sub-Total of Current Liabilities |
634,046,132.64 |
| Long-term Loans |
121,228,962.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,894,821.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
142,456,401.59 |
| Total Liabilities |
776,502,534.23 |
| Paid-In Capital(Or Share Stock) |
217,154,880.00 |
| Capital Surplus |
304,085,954.46 |
| Surplus Reserve |
41,394,875.75 |
| LESS:Treasury Stock |
11,598,105.00 |
| Undistributed Profits |
416,164,876.88 |
| Minority Stockholder's Interest |
49,621,402.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
973,338,148.14 |
| Owner's Equity（Stockholder's Equity） |
1,022,959,550.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,799,462,084.64 |
